Literature DB >> 10603010

Midface surgery from Tessier to distraction.

D Marchac1, E Arnaud.   

Abstract

The wall separating the face and the cranium was broken by Paul Tessier and Gérard Guiot in the 1960s, making it possible to perform a combined operation around the orbits and forehead, and opening up close cooperation between plastic surgeons and neurosurgeons, especially for treatment of the major malformations such as hypertelorism of major facial retrusions. The principles of mobilization of the orbits to correct teleorbitism or orbital dystopia are recalled with reference to the different variations and with clinical examples. Facial advancement to correct the retrusions created by faciocraniosynostosis is explained with the many possible variants, combined with a intracranial approach or not, with or without a bipartition. The indications are discussed as is the risk linked to combined advancement of face and forehead. The progressive bone elongation principle introduced by Ilizarov for the limbs has been applied to the face at the mandibular level by McCarthy, with great success. The distraction of bone structures is now also applied at the level of the midface and makes it possible to overcome the retraction of soft tissues and lower the risk of relapse of facial retrusion. Many technical problems have still to be solved, but the results are already very promising. Many other applications of the distraction principle will be developed for the midface level, with other technical improvements such as the use of absorbable mini-plates and screws.

Entities:  

Mesh:

Year:  1999        PMID: 10603010     DOI: 10.1007/s003810050458

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  9 in total

1.  Midface Morphology and Growth in Syndromic Craniosynostosis Patients Following Frontofacial Monobloc Distraction.

Authors:  Cristiano Tonello; Lucia H S Cevidanes; Antonio C O Ruellas; Nivaldo Alonso
Journal:  J Craniofac Surg       Date:  2021 Jan-Feb 01       Impact factor: 1.046

2.  Posterior cranial vault distraction osteogenesis in craniosynostosis: estimated increases in intracranial volume.

Authors:  Willy S Serlo; Leena P Ylikontiola; Niina Lähdesluoma; Olli-Pekka Lappalainen; Jarkko Korpi; Jani Verkasalo; George K B Sàndor
Journal:  Childs Nerv Syst       Date:  2010-12-02       Impact factor: 1.475

3.  Distraction vs remodeling surgery for craniosynostosis.

Authors:  Seong-Woong Kim; Kyu-Won Shim; Nick Plesnila; Yong-Oock Kim; Joong-Uhn Choi; Dong-Seok Kim
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

4.  Faciocraniosynostosis: monobloc frontofacial osteotomy replacing the two-stage strategy?

Authors:  E Arnaud; F Di Rocco
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

5.  Median facial cleft with a frontoethmoidal encephalocele treated with craniofacial bipartition and free radial forearm flap: a case report.

Authors:  Marton König; Bernt Due-Tønnessen; Terje Osnes; Jan-Ragnar Haugstvedt; Torstein R Meling
Journal:  Skull Base       Date:  2010-03

6.  Fifteen years of experience with the midfacial distraction without maxillary osteotomy protocol.

Authors:  Edouard Coeugniet; Philippe Pellerin; Alexis Wolber; Patrick Dhellemmes; Mathieu Vinchon
Journal:  Childs Nerv Syst       Date:  2013-11-26       Impact factor: 1.475

7.  Unfavourable results with distraction in craniofacial skeleton.

Authors:  Rajiv Agarwal
Journal:  Indian J Plast Surg       Date:  2013-05

8.  Experience with craniosynostosis treatment using posterior cranial vault distraction osteogenesis.

Authors:  Leena P Ylikontiola; George K Sándor; Niina Salokorpi; Willy S Serlo
Journal:  Ann Maxillofac Surg       Date:  2012-01

Review 9.  A critical appraisal of surgical outcomes following orbital hypertelorism correction: what is the incidence of true bony relapse versus soft tissue telecanthus?

Authors:  Beatrice C Go; Sameer Shakir; Jordan W Swanson; Scott P Bartlett; Jesse A Taylor
Journal:  Childs Nerv Syst       Date:  2020-09-22       Impact factor: 1.532

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.